患有心脏瓣膜病的心力衰竭患者的院内结局:来自真实世界理赔数据的见解
In-Hospital Outcomes of Heart Failure Patients with Valvular Heart Disease: Insights from Real-World Claims Data.
作者信息
Izumi Chisato, Matsuyama Rei, Yamabe Kaoru, Iwasaki Kosuke, Takeshima Tomomi, Murphy Shannon M E, Teng Lida, Igarashi Ataru
机构信息
Division of Heart Failure, Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan.
Market Access, Edwards Lifesciences Limited, Tokyo, Japan.
出版信息
Clinicoecon Outcomes Res. 2023 May 18;15:349-360. doi: 10.2147/CEOR.S405079. eCollection 2023.
PURPOSE
Heart failure (HF) is a serious public health burden that is rapidly increasing in the aging population. Valvular heart disease (VHD) is a known etiology of heart failure (HF); however, the impact of VHD on outcomes of patients with HF has not been well-studied in Japan. This study aimed to determine the rates of VHD in Japanese patients admitted for HF and explore associations of VHD with in-hospital outcomes through a claim-based analysis.
PATIENTS AND METHODS
We analyzed claims data from 86,763 HF hospitalizations (January 2017 through December 2019) from the Medical Data Vision database. Common etiologies of HF were examined, then hospitalizations were categorized into those with VHD and those without. Covariate-adjusted models were used to explore the association of VHD with in-hospital mortality, length of stay, and medical cost.
RESULTS
Of 86,763 hospitalizations for HF, 13,183 had VHD and 73,580 did not. VHD was the second most frequent etiology of HF (15.2%). The most frequent type of VHD was mitral regurgitation (36.4% of all hospitalizations with VHD), followed by aortic stenosis (33.7%) and aortic regurgitation (16.4%). There was no significant difference in in-hospital mortality between hospitalizations with VHD vs those without (9.0% vs 8.9%; odds ratio [95% CI]: 1.01 [0.95-1.08]; p=0.723). Hospitalizations with VHD were associated with significantly longer length of stay (26.1 vs 24.8 days; incident rate ratio [95% CI]: 1.05 [1.03-1.07]; p<0.001) and higher medical costs (1536 vs 1195 thousand yen; rate ratio [95% CI]: 1.29 [1.25-1.32]; p<0.001).
CONCLUSION
VHD was a frequent etiology of HF that was associated with significant medical resource use. Future studies are needed to investigate whether timely VHD treatment could reduce HF progression and its associated healthcare resource utilization.
目的
心力衰竭(HF)是一项严重的公共卫生负担,且在老年人群中迅速增加。心脏瓣膜病(VHD)是已知的心力衰竭病因;然而,在日本,VHD对心力衰竭患者预后的影响尚未得到充分研究。本研究旨在通过基于索赔的分析确定因心力衰竭入院的日本患者中VHD的发生率,并探讨VHD与住院结局的关联。
患者与方法
我们分析了来自医疗数据视觉数据库的86763例心力衰竭住院病例(2017年1月至2019年12月)的索赔数据。对心力衰竭的常见病因进行了检查,然后将住院病例分为有VHD和无VHD两组。使用协变量调整模型来探讨VHD与住院死亡率、住院时间和医疗费用之间的关联。
结果
在86763例心力衰竭住院病例中,13183例有VHD,73580例无VHD。VHD是心力衰竭的第二常见病因(15.2%)。最常见的VHD类型是二尖瓣反流(在所有有VHD的住院病例中占36.4%),其次是主动脉瓣狭窄(33.7%)和主动脉瓣反流(16.4%)。有VHD的住院病例与无VHD的住院病例在住院死亡率上无显著差异(9.0%对8.9%;优势比[95%置信区间]:1.01[0.95 - 1.08];p = 0.723)。有VHD的住院病例住院时间显著更长(26.1天对24.8天;发生率比[95%置信区间]:1.05[1.03 - 1.07];p < 0.001),医疗费用更高(153.6万日元对119.5万日元;率比[95%置信区间]:l.29[1.25 - 1.32];p < 0.001)。
结论
VHD是心力衰竭的常见病因,与大量医疗资源的使用相关。未来需要开展研究,以调查及时治疗VHD是否能减少心力衰竭的进展及其相关的医疗资源利用。